Maheen Z. Abidi

Maheen Z. Abidi

Auto-generated profile, based on publicly available information

Maheen Z. Abidi

Department of medicine, Division of Infectious Diseases University of Colorado Anschutz Medical Campus Denver Colorado USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2019 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
MAMaheen Z. Abidi
Maheen Z. Abidi
PHParameswaran Hari
Parameswaran Hari
MCMin Chen
Min Chen
SKSoyoung Kim
Soyoung Kim
MBMinoo Battiwala
Minoo Battiwala
MRMarcie Riches
Marcie Riches

26 November 2019 in Transplant Infectious Disease
Verified
Journal Article
Closed access
PDF file
PRPoornima Ramanan
Poornima Ramanan
SSSias Scherger
Sias Scherger
EBEsther Benamu
Esther Benamu
VBValida Bajrovic
Valida Bajrovic
WJWhitney Jackson
Whitney Jackson
MAMaheen Z. Abidi
Maheen Z. Abidi

23 October 2016 in Case Reports in Hematology
Verified
Journal Article
Open access
PDF file
MAMaheen Z. Abidi
Maheen Z. Abidi
JHJaveria Haque
Javeria Haque
PVParvathi Varma
Parvathi Varma
HOHoratiu Olteanu
Horatiu Olteanu
GMGuru Subramanian Guru Murthy
Guru Subramanian Guru Murthy
PHParameswaran Hari
Parameswaran Hari
Ruxolitinib is widely in use for treatment of myeloproliferative disorders. It causes inhibition of the Janus kinase (JAK) signal transducer and activation of transcription (STAT) pathway, which plays a key role in the underlying pathophysiology of myeloproliferative diseases. We describe a case of reactivation pulmonary tuberculosis in a retired physician while on treatment with ruxolitinib. We also review the literature on opportunistic infections following use of ruxolitinib. Our case highlights the importance of screening for latent tuberculosis in patients from highly endemic areas prior to start of therapy with ruxolitinib.

16 April 2018 in Case Reports in Medicine
Verified
Journal Article
Open access
PDF file
JLJessica Lum
Jessica Lum
MAMaheen Z. Abidi
Maheen Z. Abidi
BMBruce McCollister
Bruce McCollister
Andrés Henao-MartinezAndrés Henao-Martinez
Andrés Henao-Martinez
Miliary histoplasmosis is a rare presentation that may mimic miliary tuberculosis. We report a case of miliary histoplasmosis in a 52-year-old male who was being treated with hydroxychloroquine, methotrexate, and sulfasalazine for his rheumatoid arthritis and presented to the emergency department with shortness of breath and fevers. Computed tomography (CT) chest revealed miliary pulmonary nodules. UrineHistoplasmaantigen and serumHistoplasmaantigen were negative; however,Coccidioides immitiscomplement immunofixation assay andCoccidioidesIgM were positive. The patient was initiated on treatment for pulmonary coccidioidomycosis and immunosuppression was held. However, a few days later,Histoplasma capsulatumwas isolated from cultures from bronchoscopy. This case highlights the difficulty in diagnosing histoplasmosis in immunocompromised patients and the importance of having a broad differential diagnosis for miliary pulmonary nodules. Tissue culture and histopathology remain the gold standard for the diagnosis of histoplasmosis. Further research needs to be conducted to determine the optimal duration of histoplasmosis treatment in immunocompromised patients.

12 July 2023 in Transplant Infectious Disease
Verified
Journal Article
Closed access
MAMaheen Z. Abidi
Maheen Z. Abidi
KMKyle C. Molina
Kyle C. Molina
KGKrystle Garth
Krystle Garth
JGJonathan A. Gutman
Jonathan A. Gutman
AWAdriana Weinberg
Adriana Weinberg

27 November 2024 in Transplant Infectious Disease
Verified
Journal Article
Closed access
DLDong Heun Lee
Dong Heun Lee
MAMaheen Z. Abidi
Maheen Z. Abidi
CFCynthia Fisher
Cynthia Fisher
AHAnna L. Hughart
Anna L. Hughart
MTMitsuru Toda
Mitsuru Toda
LDLara Danziger‐Isakov
Lara Danziger‐Isakov